Civic AI
Procurement intelligence
Federal contract award
NICHD: R&D: TO EVALUATE IN OBESE AND NON-OBESE WOMEN THE PHARMACOKINETICS AND THE PHARMACODYMANIC EFFECTS, CYCLE CONTROL, AND SAFETY OF LEVONORGESTREL BUTANOATE (LB) FORMULATED AS A LONG ACTING INJECTABLE: NON-SEVERABLE
UNIVERSITY OF CALIFORNIA, DAVIS · Department of Health and Human Services
- Value
- $1,088,133
- Start
- Sep 25, 2018
- End
- Jul 14, 2026
- Action date
- Mar 17, 2026
- PIID
- 75N94018F00004
- Status
- completed
- NAICS
- 541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
- Place of performance
- DAVIS, CA
- Award type
- DELIVERY ORDER
Description
NICHD: R&D: TO EVALUATE IN OBESE AND NON-OBESE WOMEN THE PHARMACOKINETICS AND THE PHARMACODYMANIC EFFECTS, CYCLE CONTROL, AND SAFETY OF LEVONORGESTREL BUTANOATE (LB) FORMULATED AS A LONG ACTING INJECTABLE: NON-SEVERABLE
Need modifications, related awards, and vendor peers? Open the full award workspace.